Press Releases Year None202420232022202120202019201820172015 April 5, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 4, 2024 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences March 11, 2024 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates March 6, 2024 ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference March 5, 2024 ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting March 1, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) February 14, 2024 ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit February 2, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) January 31, 2024 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences January 22, 2024 ORIC Pharmaceuticals Announces $125 Million Private Placement Financing Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last » Displaying 21 - 30 of 32
OricPharma logo
